CVRX INC (CVRX) Stock Fundamental Analysis

NASDAQ:CVRX • US1266381052

5.28 USD
+0.43 (+8.87%)
At close: Feb 19, 2026
5.28 USD
0 (0%)
After Hours: 2/19/2026, 4:39:15 PM
Fundamental Rating

2

Taking everything into account, CVRX scores 2 out of 10 in our fundamental rating. CVRX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of CVRX is average, but there are quite some concerns on its profitability. CVRX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CVRX has reported negative net income.
  • In the past year CVRX has reported a negative cash flow from operations.
  • CVRX had negative earnings in each of the past 5 years.
  • In the past 5 years CVRX always reported negative operating cash flow.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -46.73%, CVRX is doing worse than 65.95% of the companies in the same industry.
  • CVRX's Return On Equity of -108.26% is on the low side compared to the rest of the industry. CVRX is outperformed by 62.16% of its industry peers.
Industry RankSector Rank
ROA -46.73%
ROE -108.26%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

  • The Gross Margin of CVRX (84.49%) is better than 93.51% of its industry peers.
  • CVRX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

  • CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CVRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • CVRX has an Altman-Z score of -6.02. This is a bad value and indicates that CVRX is not financially healthy and even has some risk of bankruptcy.
  • CVRX has a Altman-Z score of -6.02. This is in the lower half of the industry: CVRX underperforms 69.19% of its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that CVRX has dependencies on debt financing.
  • The Debt to Equity ratio of CVRX (1.03) is worse than 76.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z -6.02
ROIC/WACCN/A
WACC10.46%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 9.62 indicates that CVRX has no problem at all paying its short term obligations.
  • CVRX's Current ratio of 9.62 is amongst the best of the industry. CVRX outperforms 91.35% of its industry peers.
  • CVRX has a Quick Ratio of 8.60. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CVRX (8.60) is better than 90.81% of its industry peers.
Industry RankSector Rank
Current Ratio 9.62
Quick Ratio 8.6
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 23.79% over the past year.
EPS 1Y (TTM)23.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.45%

3.2 Future

  • CVRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.35% yearly.
  • The Revenue is expected to grow by 21.21% on average over the next years. This is a very strong growth
EPS Next Y3.82%
EPS Next 2Y9.08%
EPS Next 3Y11.55%
EPS Next 5Y8.35%
Revenue Next Year15.14%
Revenue Next 2Y17.45%
Revenue Next 3Y19.86%
Revenue Next 5Y21.21%

3.3 Evolution

CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -5 -10 -15 -20

0

4. Valuation

4.1 Price/Earnings Ratio

  • CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.08%
EPS Next 3Y11.55%

0

5. Dividend

5.1 Amount

  • No dividends for CVRX!.
Industry RankSector Rank
Dividend Yield 0%

CVRX INC

NASDAQ:CVRX (2/19/2026, 4:39:15 PM)

After market: 5.28 0 (0%)

5.28

+0.43 (+8.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners60.26%
Inst Owner Change3.64%
Ins Owners4.32%
Ins Owner Change0%
Market Cap138.39M
Revenue(TTM)N/A
Net Income(TTM)-52.02M
Analysts80
Price Target11.73 (122.16%)
Short Float %6.89%
Short Ratio5.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.64%
Min EPS beat(2)-7.47%
Max EPS beat(2)4.2%
EPS beat(4)2
Avg EPS beat(4)-1.64%
Min EPS beat(4)-12.12%
Max EPS beat(4)8.82%
EPS beat(8)3
Avg EPS beat(8)-13.78%
EPS beat(12)7
Avg EPS beat(12)-5.22%
EPS beat(16)10
Avg EPS beat(16)-3.7%
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.76%
Max Revenue beat(2)1.73%
Revenue beat(4)2
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)1.73%
Revenue beat(8)2
Avg Revenue beat(8)-2.21%
Revenue beat(12)6
Avg Revenue beat(12)0.45%
Revenue beat(16)9
Avg Revenue beat(16)0.97%
PT rev (1m)0%
PT rev (3m)-0.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.92%
EPS NY rev (1m)0%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.47
P/FCF N/A
P/OCF N/A
P/B 2.88
P/tB 2.88
EV/EBITDA N/A
EPS(TTM)-2.05
EYN/A
EPS(NY)-1.97
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS2.14
BVpS1.83
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.73%
ROE -108.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.49%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75.3%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.62
Quick Ratio 8.6
Altman-Z -6.02
F-Score3
WACC10.46%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.98%
EPS Next Y3.82%
EPS Next 2Y9.08%
EPS Next 3Y11.55%
EPS Next 5Y8.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.45%
Revenue Next Year15.14%
Revenue Next 2Y17.45%
Revenue Next 3Y19.86%
Revenue Next 5Y21.21%
EBIT growth 1Y14.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.07%
EBIT Next 3Y7.78%
EBIT Next 5Y9.76%
FCF growth 1Y8.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.57%
OCF growth 3YN/A
OCF growth 5YN/A

CVRX INC / CVRX FAQ

Can you provide the ChartMill fundamental rating for CVRX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CVRX.


What is the valuation status for CVRX stock?

ChartMill assigns a valuation rating of 0 / 10 to CVRX INC (CVRX). This can be considered as Overvalued.


Can you provide the profitability details for CVRX INC?

CVRX INC (CVRX) has a profitability rating of 1 / 10.


Can you provide the financial health for CVRX stock?

The financial health rating of CVRX INC (CVRX) is 4 / 10.